person
Carlos G. R.
- Country
- France
- Department
- Oncologie Médicale
Research Overview
assignment
25
Clinical Trials ·
- Evaluation of MAQ-001 Monotherapy and Combination Therapy in Advanced Cancers with Approved Immune Checkpoint Blockade Options
- Safety, Pharmacokinetics, and Efficacy of RO7567132 Alone and with Atezolizumab in Patients with Advanced or Metastatic Solid Tumors
- First-in-Human Trial of DS3610a in Participants with Advanced Solid Tumors
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
60
Sites with multiple studies
Has run more than one trial at 60 of 123 partner sites.
Specializations
Advanced Cancer Research
Specializes in clinical investigation of advanced and metastatic solid tumors across multiple therapeutic approaches and cancer types.
- Tumor-Agnostic Treatment Strategies
- Novel Immunotherapy Combinations
- Molecular Targeted Therapies
Specialized Cancer Focus
Conducts research across diverse cancer types with particular emphasis on HER2-expressing cancers and squamous cell carcinomas.
- Head and Neck Cancer
- Renal Cell Carcinoma
- Lung Cancer
- Hepatocellular Carcinoma
Precision Medicine Applications
Investigates biomarker-driven treatment approaches and molecular alterations in cancer therapy.
- Genetic Mutation Analysis
- Targeted Drug Development
- Personalized Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.